Notice2024-05387
Agency Forms Undergoing Paperwork Reduction Act Review
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
March 14, 2024
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 51 (Thursday, March 14, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 51 (Thursday, March 14, 2024)]
[Notices]
[Pages 18637-18638]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-05387]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-24-1385]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``Characteristics of Cases of Priority Fungal
Diseases'' to the Office of Management and Budget (OMB) for review and
approval. CDC previously published a ``Proposed Data Collection
Submitted for Public Comment and Recommendations'' notice on December
11, 2023 to obtain comments from the public and affected agencies. CDC
received one comment related to the previous notice. This notice serves
to allow an additional 30 days for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to <a href="http://www.reginfo.gov/public/do/PRAMain">www.reginfo.gov/public/do/PRAMain</a>. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
Characteristics of Cases of Priority Fungal Diseases (OMB Control
No. 0920-1385, Exp. 3/31/2026)--Revision--National Center for Emerging
and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
Fungal diseases cause substantial illness, ranging from mild
infection to severe or life-threatening invasive disease. They also
constitute a considerable financial burden on patients and healthcare
systems. Awareness of fungal diseases is low, and data collection has
historically been limited in size, scope, and coordination, which has
hindered our understanding of these diseases. Detailed epidemiologic
and clinical data are critical to inform appropriate public health
responses. We plan to enhance surveillance of high priority fungal
diseases across the United States to better characterize factors such
as disease burden, geographic scope, patient risk factors, health
disparities, healthcare utilization, outcomes, and emerging trends.
This project will serve as a Revision of the information collections
project: Triazole-resistant Aspergillus fumigatus Case Report Form
(CRF). The Revision will expand the number of fungal diseases for which
data may be collected.
CDC requests to change the name of this information collection
project from Triazole-resistant Aspergillus fumigatus Case Report Form
to Characteristics of Cases of Priority Fungal Diseases. In addition to
triazole-resistant A. fumigatus infections, CRFs have also been
developed for coccidioidomycosis, histoplasmosis, blastomycosis, C.
auris, and antifungal-resistant dermatophytosis. We plan to use
standardized CRFs to collect public health surveillance data for cases
of these diseases regarding demographics (e.g., age, sex, race/
ethnicity, location of residence), underlying medical conditions,
diagnosis (e.g., clinical presentation, laboratory testing),
treatments, and outcomes (e.g., hospitalization, vital status). The
corresponding CRF would be filled out voluntarily by State and local
health departments and contains a section for medical chart review and
an optional supplemental interview (including data on potential
occupational or environmental exposures) of the patient or their
representative. Findings can help identify populations at higher risk
of these diseases, detect emerging epidemiologic trends, and guide
prevention and response efforts. They can also help better focus public
and healthcare provider outreach, inform efforts to contain or mitigate
spread, and influence health policy and research on prevention and
treatment.
CDC requests OMB approval for an estimated 1,138 annual burden
hours. There is no cost to respondents other than their time to
participate.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Type of respondent Form name respondents responses per response (in
respondent hours)
----------------------------------------------------------------------------------------------------------------
State and Local Health Departments.... Triazole-resistant 15 15 0.5
Aspergillus fumigatus
Case Report Form.
State and Local Health Departments.... Coccidioidomycosis Case 10 25 1.0
Report Form.
State and Local Health Departments.... Histoplasmosis Case 10 25 1.0
Report Form.
State and Local Health Departments.... Blastomycosis Case 10 25 1.0
Report Form.
State and Local Health Departments.... Candida auris Case 15 20 45/60
Report Form.
[[Page 18638]]
State and Local Health Departments.... Antifungal-resistant 10 10 0.5
dermatophytosis case
report form.
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health
Ethics and Regulations, Office of Science, Centers for Disease Control
and Prevention.
[FR Doc. 2024-05387 Filed 3-13-24; 8:45 am]
BILLING CODE 4163-18-P
</pre></body>
</html>Indexed from Federal Register on March 14, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.